FDA Gives Thumbs Up To Multiple Sclerosis Drug From Novartis The Food and Drug Administration approved a Novartis drug that can help patients with relapsing forms of multiple sclerosis. Mayzent (siponimod) showed benefits in delaying the progression of disability and cognitive decline. by Milafel Dacanay
Health Ocrelizumab Shown Effective Against Relapsing, Progressive Forms Of Multiple Sclerosis by Saranya Palanisamy